Literature DB >> 19348928

Combined sensitization of mice to extracts of dust mite, ragweed, and Aspergillus species breaks through tolerance and establishes chronic features of asthma.

Nicholas Goplen1, M Zunayet Karim, Qiaoling Liang, Magdalena M Gorska, Sadee Rozario, Lei Guo, Rafeul Alam.   

Abstract

BACKGROUND: Existing asthma models develop tolerance when chronically exposed to the same allergen.
OBJECTIVE: We sought to establish a chronic model that sustains features of asthma long after discontinuation of allergen exposure.
METHODS: We immunized and exposed mice to a combination of single, double, or triple allergens (dust mite, ragweed, and Aspergillus species) intranasally for 8 weeks. Airway hyperreactivity (AHR) and morphologic features of asthma were studied 3 weeks after allergen exposure. Signaling effects of the allergens were studied on dendritic cells.
RESULTS: Sensitization and repeated exposure to a single allergen induced tolerance. Sensitization to double and especially triple allergens broke through tolerance and established AHR, eosinophilic inflammation, mast cell and smooth muscle hyperplasia, mucus production, and airway remodeling that persisted at least 3 weeks after allergen exposure. Mucosal exposure to triple allergens in the absence of an adjuvant was sufficient to induce chronic airway inflammation. Anti-IL-5 and anti-IL-13 antibodies inhibited inflammation and AHR in the acute asthma model but not in the chronic triple-allergen model. Multiple allergens produce a synergy in p38 mitogen-activated protein kinase signaling and maturation of dendritic cells, which provides heightened T-cell costimulation at a level that cannot be achieved with a single allergen.
CONCLUSIONS: Sensitivity to multiple allergens leads to chronic asthma in mice. Multiple allergens synergize in dendritic cell signaling and T-cell stimulation that allows escape from the single allergen-associated tolerance development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19348928      PMCID: PMC2683988          DOI: 10.1016/j.jaci.2009.02.009

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  35 in total

1.  Reversal of allergic airway hyperreactivity after long-term allergen challenge depends on gammadelta T cells.

Authors:  Zhi-Hua Cui; Anthony Joetham; M Kemal Aydintug; Yoon-Soo Hahn; Willi K Born; Erwin W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  2003-12-01       Impact factor: 21.405

2.  Fungal proteases induce Th2 polarization through limited dendritic cell maturation and reduced production of IL-12.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Rachel Elizabeth Martin; Tomoki Ito; Farrah Kheradmand; David Brian Corry; Yong-Jun Liu; Matthew Moyle
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

3.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

4.  Allergen-induced airway disease is mouse strain dependent.

Authors:  Gregory S Whitehead; Julia K L Walker; Katherine G Berman; W Michael Foster; David A Schwartz
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-03-07       Impact factor: 5.464

5.  A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease.

Authors:  Farrah Kheradmand; Attila Kiss; Jie Xu; Seung-Hyo Lee; Pappachan E Kolattukudy; David B Corry
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

6.  Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice.

Authors:  Kenji Takabayashi; Lev Libet; Dugald Chisholm; Jose Zubeldia; Anthony A Horner
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

7.  The role of IL-13 in established allergic airway disease.

Authors:  Christian Taube; Catherine Duez; Zhi-Hua Cui; Katsuyuki Takeda; Yeong-Ho Rha; Jung-Won Park; Annette Balhorn; Debra D Donaldson; Azzeddine Dakhama; Erwin W Gelfand
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

8.  Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations.

Authors:  Shinichiro Tomioka; Jason H T Bates; Charles G Irvin
Journal:  J Appl Physiol (1985)       Date:  2002-07

9.  Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity.

Authors:  Husein Hadeiba; Richard M Locksley
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

10.  A novel mouse model of experimental asthma.

Authors:  Sampson B Sarpong; Liu-Yi Zhang; Steven R Kleeberger
Journal:  Int Arch Allergy Immunol       Date:  2003-12       Impact factor: 2.749

View more
  38 in total

1.  ERK1 is important for Th2 differentiation and development of experimental asthma.

Authors:  Nicholas Goplen; Zunayet Karim; Lei Guo; Yonghua Zhuang; Hua Huang; Magdalena M Gorska; Erwin Gelfand; Gilles Pagés; Jacques Pouysségur; Rafeul Alam
Journal:  FASEB J       Date:  2012-01-18       Impact factor: 5.191

2.  Lyn mitigates mouse airway remodeling by downregulating the TGF-β3 isoform in house dust mite models.

Authors:  Guoping Li; John Fox; Zhigang Liu; Jun Liu; George F Gao; Yang Jin; Hongwei Gao; Min Wu
Journal:  J Immunol       Date:  2013-10-14       Impact factor: 5.422

Review 3.  Animal models of asthma.

Authors:  Jason H T Bates; Mercedes Rincon; Charles G Irvin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-06-26       Impact factor: 5.464

4.  Experimental asthma persists in IL-33 receptor knockout mice because of the emergence of thymic stromal lymphopoietin-driven IL-9+ and IL-13+ type 2 innate lymphoid cell subpopulations.

Authors:  Mukesh Verma; Sucai Liu; Lidia Michalec; Anand Sripada; Magdalena M Gorska; Rafeul Alam
Journal:  J Allergy Clin Immunol       Date:  2017-11-10       Impact factor: 10.793

5.  MicroRNA Targets for Asthma Therapy.

Authors:  Sabrina C Ramelli; William T Gerthoffer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation.

Authors:  Gye Young Park; Yong Gyu Lee; Evgeny Berdyshev; Sharmilee Nyenhuis; Jian Du; Panfeng Fu; Irina A Gorshkova; Yongchao Li; Sangwoon Chung; Manjula Karpurapu; Jing Deng; Ravi Ranjan; Lei Xiao; H Ari Jaffe; Susan J Corbridge; Elizabeth A B Kelly; Nizar N Jarjour; Jerold Chun; Glenn D Prestwich; Eleanna Kaffe; Ioanna Ninou; Vassilis Aidinis; Andrew J Morris; Susan S Smyth; Steven J Ackerman; Viswanathan Natarajan; John W Christman
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

7.  Anti-Asthma Simplified Herbal Medicine Intervention-induced long-lasting tolerance to allergen exposure in an asthma model is interferon-γ, but not transforming growth factor-β dependent.

Authors:  K Srivastava; T Zhang; N Yang; H Sampson; X M Li
Journal:  Clin Exp Allergy       Date:  2010-11       Impact factor: 5.018

8.  Multi-allergen challenge stimulates steriod-resistant airway inflammation via NF-κB-mediated IL-8 expression.

Authors:  Renping Liu; Jinye Bai; Guoshun Xu; Lingling Xuan; Tianqi Zhang; Aiming Meng; Qi Hou
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

9.  Understanding asthma using animal models.

Authors:  Yoo Seob Shin; Katsuyuki Takeda; Erwin W Gelfand
Journal:  Allergy Asthma Immunol Res       Date:  2009-09-25       Impact factor: 5.764

10.  Neutralisation of interleukin-13 in mice prevents airway pathology caused by chronic exposure to house dust mite.

Authors:  Kate L Tomlinson; Gareth C G Davies; Daniel J Sutton; Roger T Palframan
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.